BIOSURFACES

Address

200 Homer Avenue, Unit 1P
ASHLAND, MA, 01721-1717

Information

DUNS: 131658739
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease

    Amount: $150,000.00

    PROJECT SUMMARY Cardiac valve repair or replacement is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting ...

    SBIRPhase I2014Department of Health and Human Services
  2. A Nanofibrous Bioactive Hemodialysis Access Graft

    Amount: $988,074.00

    DESCRIPTION (provided by applicant): Current gold standards for hemodialysis access to treat End-Stage Renal Disease (ESRD), radial cephalic vein fistulas and autogenous saphenous veins, have signific ...

    SBIRPhase II2012Department of Health and Human Services
  3. A Bioactive Prosthetic Vascular Graft

    Amount: $748,950.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are primarily comprised of polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted i ...

    STTRPhase II2011Department of Health and Human Services
  4. A Nanofibrous Bioactive Hemodialysis Access Graft

    Amount: $111,079.00

    DESCRIPTION (provided by applicant): Current gold standards for hemodialysis access, radial cephalic vein fistulas and autogenous saphenous veins, have significant problems associated with their use. ...

    SBIRPhase I2010Department of Health and Human Services
  5. A Nanofibrous Bioactive Prosthetic Sewing Cuff

    Amount: $110,528.00

    DESCRIPTION (provided by applicant): Cardiac valve replacement using prosthetic valves is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvu ...

    STTRPhase I2009Department of Health and Human Services
  6. A Bioactive Prosthetic Vascular Graft

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in ...

    STTRPhase I2008Department of Health and Human Services
  7. An Endothelial Progenitor Cell-Specific Nanofibrous Vascular Graft

    Amount: $499,998.00

    DESCRIPTION (provided by applicant): Over 60,000 prosthetic grafts, which are comprised of either polyethylene terephthalate (polyester) or expanded polytetrafluoroethylene (ePTFE), are implanted in ...

    SBIRPhase I2008Department of Health and Human Services
  8. STTR Phase I: Localized Gene Delivery from Implantable Arterial Devices

    Amount: $150,000.00

    This Small Business Technology Transfer (STTR) Phase I research project aims to develop a fibrous material for the embedment and gradual release of appropriate genetic material, including small interf ...

    STTRPhase I2007National Science Foundation
  9. Development of Infection-Resistant Suture Materials

    Amount: $744,617.00

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4-mi ...

    STTRPhase II2006Department of Health and Human Services
  10. A Nanofibrous Biocomposite Small-Diameter Graft

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): There is no small-diameter (< 5mm internal diameter) vascular prosthesis approved for clinical use in small vessel reconstruction. Current prostheses are not ca ...

    SBIRPhase II2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government